New drug cocktail tested for Tough-to-Treat bile duct cancer
NCT ID NCT05052099
Summary
This study tested a combination of three drugs (a chemotherapy, an immunotherapy, and a blood vessel blocker) for people with advanced bile duct cancer whose disease progressed after one prior treatment. The goal was to see if this combination could shrink tumors and control the disease better than existing options, while monitoring side effects. All 20 participants received the drug combination until their cancer worsened or they experienced unacceptable side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clínica Universidad de Navarra
Pamplona, 31008, Spain
-
Universitätsklinikum Essen
Essen, North Rhine-Westphalia, 45147, Germany
Conditions
Explore the condition pages connected to this study.